U.S. Healthtech Stock News

NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Joins Russell 2000 As Investors Ask If The Turnaround Is Priced In

Newell Brands (NWL) is at the center of a broad reshuffle across Russell indices, with the stock moving out of the Russell 1000 and Russell Midcap indices and into several Russell 2000 variants. See our latest analysis for Newell Brands. The Russell index reshuffle comes at a time when Newell Brands' share price has shown strong short term momentum, with a 30 day share price return of 80.59% and a year to date share price return of 65.05%, even as the 5 year total shareholder return is down...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Maplebear (CART) Joins Russell Growth Indexes As Valuation Debate Tightens

Index additions put Maplebear in front of more growth-focused investors Maplebear (CART) has been added to several Russell growth benchmarks, including the Russell 1000 Growth and Russell 3000 Growth, a move that can influence trading as index funds rebalance. See our latest analysis for Maplebear. These index additions come as Maplebear’s 30 day share price return of 18.97% and 90 day share price return of 22.54% point to building momentum, while the 1 year total shareholder return of 3.75%...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Warner Bros. Discovery (WBD) Stock May Be 12% Undervalued Despite Merger Scrutiny

Warner Bros. Discovery stock has delivered a 143.7% return over the past year, yet a mixed valuation score and discounted intrinsic value estimate keep the question open on how much upside, if any, is still reflected in the current price. The 143.7% one year return highlights how strongly sentiment has swung in favor of Warner Bros. Discovery, which raises the hurdle for fresh buyers looking for value. On the positive side, the proposed $110b acquisition by Paramount Skydance and moves like...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative?

In late June 2026, Certara, Inc. was removed from several large- and mid-cap Russell indices and added to the Russell 2000 and related value and dynamic benchmarks, reflecting a reclassification toward smaller-cap status within the Russell index family. A few days earlier, Certara also launched its Bio Venture Catalyst offering and announced an upcoming CFO transition, underscoring both product expansion for early-stage biotech clients and evolving financial leadership. We’ll now examine how...
NYSE:ALV
NYSE:ALVAuto Components

Autoliv (ALV) Plans Americas Handover, Is The Stock Still 12% Undervalued?

Leadership transition and share structure update at Autoliv Autoliv (ALV) stock is in focus after the company announced a leadership transition in its Americas division and detailed recent changes to its share count, including retired and treasury shares. Kevin Fox, President of Autoliv Americas, plans to step down for personal reasons. He will remain in his role through August 31, 2026, then serve as executive senior advisor to the CEO until February 28, 2027. During this period, he is...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Is Microsoft (MSFT) Undervalued After Its Latest Layoffs And AI Spending Shift?

Microsoft (MSFT) is preparing another round of layoffs affecting less than 2.5% of its global workforce, as the company trims costs and shifts resources toward high capital expenditure AI projects and cloud infrastructure. See our latest analysis for Microsoft. Microsoft’s share price has fallen 17.15% over the past 30 days and is down 21.13% year to date, even though the 5 year total shareholder return of 39.99% still points to a much stronger long term record. This suggests momentum has...
NYSE:ABT
NYSE:ABTMedical Equipment

Has Abbott Laboratories (ABT) Fallen Too Far Below Fair Value?

Abbott Laboratories stock has fallen 32.0% over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and traditional valuation multiples currently point to the shares trading at a discount to underlying fundamentals. The 32.0% one year decline sets expectations low, which can create room for share prices to close the gap if the valuation signals prove accurate. Progress in areas like blood based Alzheimer’s testing and diabetes sensing technology can support long...
NYSE:CRM
NYSE:CRMSoftware

Salesforce (CRM) Faces A Fresh Valuation Test As Index Removal Shifts The Focus

Salesforce (CRM) has just been removed from several Russell growth benchmarks, including the Russell 1000 Growth and Russell Top 50 Index. This change is prompting fresh attention on how index reshuffling might affect the stock. See our latest analysis for Salesforce. For context, Salesforce shares trade at US$156.66, with the stock down about 18% on a 30 day share price return and lower by roughly 38% year to date. The 1 year total shareholder return is down about 42% and 5 year total...
NYSE:FLO
NYSE:FLOFood

Flowers Foods (FLO) Joins Russell 2000 Indexes, Is It Still Below Fair Value?

Index reshuffle puts Flowers Foods in the spotlight Flowers Foods (FLO) is at the center of a broad Russell index reshuffle, leaving several Russell 1000 and Midcap benchmarks while joining multiple Russell 2000 variants that track smaller companies and value defensive profiles. See our latest analysis for Flowers Foods. The reshuffle comes after a weak stretch for Flowers Foods, with the share price at US$7.90, a year to date share price return down 26.78% and a 1 year total shareholder...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Is Berkshire Hathaway (BRK.B) Still A Bargain Under Greg Abel?

Berkshire Hathaway stock has returned 80.4% over the past five years, yet current valuation checks suggest the market price may still sit below an estimate of intrinsic value based on the Excess Returns model and earnings multiples. The 80.4% five year return points to solid wealth creation for long term shareholders, but it also raises the bar for any further mispricing to remain. Greg Abel’s recent capital moves, including the agreed Taylor Morrison acquisition and resumed share buybacks,...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Stock Trades Below Fair Value Despite AI Optimism

Intel stock has rallied very sharply over the past year, yet the company’s own valuation checks paint a much less generous picture, leaving investors weighing a powerful AI and foundry story against signals that the shares are not an obvious bargain. Intel has delivered a roughly 5x return over the past 12 months, which sets a high bar for any further upside to be justified by future cash flows and earnings. Expectations around AI driven CPU demand and new foundry partnerships can support...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Lam Research (LRCX) Stock Looks Pricey Following Its Very Large Five Year Run

Lam Research stock has surged over a long stretch, yet its current valuation checks suggest investors are paying a clear premium for that performance. Over the past 5 years, Lam Research has returned roughly 6.3x, which puts extra focus on whether the current price already reflects much of that success. Expectations tied to AI driven demand for semiconductor equipment can support rich pricing, but concentration in areas like China and sector wide selloffs have shown how quickly sentiment...
NYSE:DEC
NYSE:DECOil and Gas

Is Diversified Energy (DEC) Undervalued As Russell Index Additions Draw More Investor Attention?

Index additions put Diversified Energy on more investor radars Diversified Energy (NYSE:DEC) was recently added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, a move that can affect how index-tracking and institutional investors view the stock. See our latest analysis for Diversified Energy. The index additions come after a mixed period for Diversified Energy, with the share price up 2.82% on the day and 7.19% over the past week, but down 17.20% over 90...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck (MRK) Wins New Drug Approvals As Its Undervalued Narrative Faces A Fresh Test

Merck (MRK) is back in focus after securing several major drug approvals and positive trial updates, along with an agreement to expand access to its new HIV treatment, IDVYNSO, through U.S. AIDS Drug Assistance Programs. See our latest analysis for Merck. Merck’s recent string of approvals and positive trial readouts has coincided with firming momentum, with a 7.44% 7 day share price return and a 20.71% year to date share price return. The 1 year total shareholder return sits at 62.32%. If...
NasdaqGM:VWAV
NasdaqGM:VWAVAerospace & Defense

Is VisionWave Holdings (VWAV) Quietly Redefining Its Edge In Autonomous Defense Interoperability?

In June 2026, VisionWave Holdings unveiled its UK-built TALON tactical autonomous aerial system and D-FLY counter-drone interceptor at Eurosatory 2026, showcasing live integration with its VARAN ground vehicle and CAEAN AI sensing platform inside the STRATUM battlefield-autonomy ecosystem. An interesting angle is that VisionWave is positioning a small-cap, allied-manufactured family of interoperable air and ground autonomous systems squarely within the fast-growing counter‑UAS and...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Is Adobe’s AI Push and Russell Value Shift Altering The Investment Case For Adobe (ADBE)?

In late June 2026, Adobe was added to several Russell value and defensive benchmarks while rolling out extensive agentic AI upgrades across Firefly, Creative Cloud, GenStudio and CX Enterprise, alongside integrating Topaz Labs’ AI models and new data collaborations such as LiveRamp for commerce media networks. Together, these moves position Adobe as an infrastructure provider for enterprise-grade, brand-safe AI content creation and customer experience management, embedding its tools more...
NYSE:COP
NYSE:COPOil and Gas

ConocoPhillips (COP) Files Shelf Registration As It Joins Two Russell Defensive Indexes

ConocoPhillips (NYSE:COP) has filed a new Shelf Registration covering multiple types of securities, providing flexibility for future capital raising or transactions. The company has also been added to the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, reflecting its inclusion in new defensive and value-oriented index baskets. ConocoPhillips is a major independent oil and gas producer, with results that tend to be closely tied to commodity prices, production...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Is Record FFO and a Higher Payout from Digital Assets Altering The Investment Case For Brookfield Infrastructure Partners (BIP)?

Brookfield Infrastructure Partners recently reported record quarterly funds from operations and increased its distribution after expanding its global digital infrastructure footprint to meet hyperscale demand. This combination of higher cash generation and a larger payout highlights the growing importance of Brookfield Infrastructure Partners’ data infrastructure segment within its diversified essential assets portfolio. We’ll now examine how this record funds-from-operations performance,...
NYSE:NKE
NYSE:NKELuxury

Nike (NKE) Stock Looks Reasonable On Cash Flow But Stretched On Earnings

NIKE’s stock has fallen sharply over the past few years, yet current checks suggest it now trades close to its estimated intrinsic value. This leaves investors weighing a steep share price decline against a valuation picture that looks more “about right” than clearly cheap. NIKE’s share price is down 72.2% over five years, which means today’s valuation is being assessed against a much lower base than in the past. Expectations that the turnaround can support future cash flows, set against...
NasdaqGS:PI
NasdaqGS:PISemiconductor

Impinj (PI) Stock Looks Fully Valued After 184% Five Year Gain

Impinj stock has delivered strong long term gains over the past five years, yet the current valuation checks and market multiples suggest the shares lean expensive rather than clearly undervalued. Impinj has returned 184.0% over five years, which puts extra focus on whether the current share price still offers enough upside for new capital. The long term case can be supported by expectations for the company to keep converting its technology and installed base into revenue growth. However,...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies (MTX) Stock May Trade At A Discount As Chapter 11 Plan Advances

Minerals Technologies stock has delivered a solid 31.1% gain over the past three years, and with the broader valuation checks pointing to an undervalued profile, the main question is whether the recent share price around US$73.97 already reflects that strength or still leaves room for further upside. Over the last three years the stock is up 31.1%, which puts recent short term pullbacks in the context of a steadily positive longer term return. The ongoing Chapter 11 proceedings linked to BMI...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Stock Looks Rich On Earnings But Reasonable On Broader Checks

Mastercard stock is up about 40.6% over the past 5 years, but with the shares recently closing at US$513.60 and screening as overvalued on earnings multiples, investors are weighing that track record against a mixed read from the valuation checks. Over 5 years, Mastercard has returned roughly 40.6%, which is a solid outcome but not necessarily a clear signal that the current price still offers an attractive entry point. On the upside, Mastercard’s push into areas such as AI powered payments,...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Is Advanced Micro Devices (AMD) Fully Valued On Its Russell Index Reshuffle?

Advanced Micro Devices (AMD) has just been dropped from several Russell value benchmarks while being added to the Russell Top 50 Index. This reshuffle changes how many index funds may hold the stock. See our latest analysis for Advanced Micro Devices. Advanced Micro Devices has been at the center of that AI driven chip rally, with a 1 day share price return of 7.7% and a 90 day share price return of 176.3%, while the 1 year total shareholder return sits at a very large level. This points to...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Raises MacBook And IPad Prices, Is The Upside Already Priced In?

Apple (AAPL) is back in focus after raising prices across key MacBook and iPad lines in response to a severe global memory chip shortage tied to AI data center demand, while simultaneously seeking U.S. approval to buy chips from Chinese supplier CXMT. See our latest analysis for Apple. Even with recent volatility around price hikes and supply chain headlines, Apple’s share price is up 13.19% over the last 90 days. Its 1 year total shareholder return of 39.79% highlights that longer term...